Internal poly(A) replacement strategy within 3′ UTR for live-attenuated tick-borne encephalitis virus
- 1Chinese Academy of Sciences, State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Wuhan, China
- 2Hubei Jiangxia Laboratory, Wuhan, China
Abstract
Tick-borne encephalitis virus (TBEV), a prominent orthoflavivirus transmitted by ticks, poses a risk of potentially fatal encephalitis in humans. Currently, the only available inactivated vaccines have limited usage, underscoring the need for developing novel vaccine strategies. The 3′ untranslated region (UTR) of TBEV can be divided into variable and conserved regions, where structured RNA elements play crucial roles in viral replication and virulence. In this study, we found that deleting sequences in both the variable region and most of the conserved region within the 3′UTR eliminated viral replication. However, inserting a poly(A) tract effectively restored viral propagation. Notably, the recovered virus variants, Δ1-642/poly(A), exhibited high attenuation in mice. A single-dose immunization with Δ1-642/poly(A) induced robust TBEV-specific IgG, neutralizing antibody, and T-cell immune responses, providing complete protection against lethal challenges with wild-type virus. Collectively, our findings demonstrate that poly(A) replacement represents a viable strategy for developing live-attenuated TBEV vaccines.
IMPORTANCE: Orthoflaviviruses, encompassing mosquito-borne dengue virus (DENV), yellow fever virus (YFV), Zika virus (ZIKV), West Nile virus (WNV), and tick-borne encephalitis virus (TBEV), represent a substantial global public health and economic burden. The 3′ UTR is critical for viral replication and pathogenesis, as exemplified by the ongoing clinical development of the tetravalent Butantan dengue vaccine (with deletion in 3′ UTR). Our previous study on WNV-poly(A) variants proposed a novel live-attenuated vaccine design via 3′ UTR engineering, yet its broad applicability remained unclear due to extensive 3′ UTR heterogeneity. In this study, we successfully rescued a TBEV poly(A) virus using an analogous strategy. This virus was highly attenuated in mice, and a single immunization provided long-term complete protection against lethal wild-type virus challenge. Collectively, our data validate the poly(A) replacement approach as a potentially universal platform for developing live-attenuated vaccines against both mosquito-borne and tick-borne orthoflaviviruses.
Related
- Partial attenuated PTH suppression of calcimimetics may be due to the resulting hypocalcemia or a significant decrease in serum calcium levels within the normal reference range without adequate calcium supplementation
- Repeated Internal Validation and Interpretation of Models Predicting Surgery Documented at a Study Institution Within 90 Days After Acute Knee Trauma: A Secondary Analysis
- Machine learning-based prediction of myocardial injury after hip replacement surgery: a single-center study with internal validation.
- Within-player associations between GPS-derived external training load and heart rate-based internal training load in elite youth male soccer training
- Development and internal validation of a simple risk stratification score for unplanned emergency department revisits within 24 hours after discharge: A retrospective observational study
BibTeX
@article{zhang2026internal,
title = {{Internal poly(A) replacement strategy within 3′ UTR for live-attenuated tick-borne encephalitis virus}},
author = {Qiu-Yan Zhang and Zhe-Rui Zhang and Cheng-Lin Deng and Jing Wang and Hong-Qing Zhang and Han-Qing Ye and Ya-Nan Zhang and Bo Zhang},
journal = {Journal of Virology},
year = {2026},
month = sep,
doi = {10.1128/jvi.00781-26},
url = {https://doi.org/10.1128/jvi.00781-26},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Internal poly(A) replacement strategy within 3′ UTR for live-attenuated tick-borne encephalitis virus
AU - Qiu-Yan Zhang
AU - Zhe-Rui Zhang
AU - Cheng-Lin Deng
AU - Jing Wang
AU - Hong-Qing Zhang
AU - Han-Qing Ye
AU - Ya-Nan Zhang
AU - Bo Zhang
PY - 2026
DA - 2026/09/16
JO - Journal of Virology
DO - 10.1128/jvi.00781-26
UR - https://doi.org/10.1128/jvi.00781-26
AB - Tick-borne encephalitis virus (TBEV), a prominent orthoflavivirus transmitted by ticks, poses a risk of potentially fatal encephalitis in humans. Currently, the only available inactivated vaccines have limited usage, underscoring the need for developing novel vaccine strategies. The 3′ untranslated region (UTR) of TBEV can be divided into variable and conserved regions, where structured RNA elements play crucial roles in viral replication and virulence. In this study, we found that deleting sequences in both the variable region and most of the conserved region within the 3′UTR eliminated viral replication. However, inserting a poly(A) tract effectively restored viral propagation. Notably, the recovered virus variants, Δ1-642/poly(A), exhibited high attenuation in mice. A single-dose immunization with Δ1-642/poly(A) induced robust TBEV-specific IgG, neutralizing antibody, and T-cell immune responses, providing complete protection against lethal challenges with wild-type virus. Collectively, our findings demonstrate that poly(A) replacement represents a viable strategy for developing live-attenuated TBEV vaccines. IMPORTANCE: Orthoflaviviruses, encompassing mosquito-borne dengue virus (DENV), yellow fever virus (YFV), Zika virus (ZIKV), West Nile virus (WNV), and tick-borne encephalitis virus (TBEV), represent a substantial global public health and economic burden. The 3′ UTR is critical for viral replication and pathogenesis, as exemplified by the ongoing clinical development of the tetravalent Butantan dengue vaccine (with deletion in 3′ UTR). Our previous study on WNV-poly(A) variants proposed a novel live-attenuated vaccine design via 3′ UTR engineering, yet its broad applicability remained unclear due to extensive 3′ UTR heterogeneity. In this study, we successfully rescued a TBEV poly(A) virus using an analogous strategy. This virus was highly attenuated in mice, and a single immunization provided long-term complete protection against lethal wild-type virus challenge. Collectively, our data validate the poly(A) replacement approach as a potentially universal platform for developing live-attenuated vaccines against both mosquito-borne and tick-borne orthoflaviviruses.
SN - 0022-538X
SN - 1098-5514
ER -